Хайлтын үр дүнгүүд - Justin F. Gainor

Үр дүнг сайжруулах
  1. 1
    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions

    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions -н Justin F. Gainor, Alice T. Shaw

    Хэвлэсэн 2013
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer -н Justin F. Gainor, Alice T. Shaw

    Хэвлэсэн 2013
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Ponatinib: Accelerated Disapproval

    Ponatinib: Accelerated Disapproval -н Justin F. Gainor, Bruce A. Chabner

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Editorial
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

    Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer -н Benjamin Herzberg, Meghan Campo, Justin F. Gainor

    Хэвлэсэн 2016
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity

    Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity -н Matthew R. Strickland, Christopher Alvarez‐Breckenridge, Justin F. Gainor, Priscilla K. Brastianos

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model

    Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model -н Christophe Dubois, Laurence Panicot‐Dubois, Justin F. Gainor, Barbara C. Furie, Bruce Furie

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer -н Justin F. Gainor, Sai‐Hong Ignatius Ou, Jennifer Logan, Lawrence F. Borges, Alice T. Shaw

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer

    Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer -н Morgan RL Lichtenstein, Ryan David Nipp, Alona Muzikansky, Kelly Goodwin, Danyon Anderson, Richard Newcomb, Justin F. Gainor

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib

    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alec... -н Justin F. Gainor, S. Andrew, Jennifer Logan, Ranliang Hu, Kevin Oh, Priscilla K. Brastianos, Helen A. Shih, Alice T. Shaw

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy

    Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy -н William L. Hwang, Andrzej Niemierko, Katie L. Hwang, Harper Hubbeling, Emily S. Lebow, Justin F. Gainor, Florence K. Keane

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States

    Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States -н Steven D. Criss, Meghan J. Mooradian, Tina R. Watson, Justin F. Gainor, Kerry L. Reynolds, Chung Yin Kong

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors

    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors -н Carmen Belli, Santosh Anand, Justin F. Gainor, Frédérique Penault‐Llorca, Vivek Subbiah, Alexander Drilon, Fabrice André, Giuseppe Curigliano

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib -н Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth A. Kennedy, Priscilla K. Brastianos, S. Andrew, Alice T. Shaw

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC -н Ibiayi Dagogo‐Jack, Sara E. Stevens, W. Marston Linehan, Rebecca J. Nagy, Lorin A. Ferris, Alice T. Shaw, Justin F. Gainor

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non–Small Cell Lung Cancer in the Context of the US Health Care System

    Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non–Small Cell Lung Cance... -н Steven D. Criss, Meghan J. Mooradian, Deirdre F. Sheehan, Leyre Zubiri, Melissa Lumish, Justin F. Gainor, Kerry L. Reynolds, Chung Yin Kong

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR -Mutant Lung Cancer Harboring De Novo MET Amplification

    Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR -Mutant Lung Cancer Harboring De Novo MET Amplification -н Justin F. Gainor, Matthew J. Niederst, Jochen K. Lennerz, Ibiayi Dagogo‐Jack, Sara E. Stevens, Alice T. Shaw, Lecia V. Sequist, Jeffrey A. Engelman

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases

    Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases -н W. Marston Linehan, Ginger Jiang, Nencyben D Joshipura, Jennifer Ackil, Subba R. Digumarthy, Sandra Rincon, Beow Y. Yeap, Justin F. Gainor, Alice T. Shaw

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Acquired Resistance to First-Line Afatinib and the Challenges of Prearranged Progression Biopsies

    Acquired Resistance to First-Line Afatinib and the Challenges of Prearranged Progression Biopsies -н Meghan Campo, David E. Gerber, Justin F. Gainor, Rebecca S. Heist, Jennifer S. Temel, Alice T. Shaw, Panos Fidias, Alona Muzikansky, Jeffrey A. Engelman, Lecia V. Sequist

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer

    Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer -н Todd M. Bauer, Alice T. Shaw, Melissa L. Johnson, Alejandro Navarro, Justin F. Gainor, Holger Thurm, Yazdi K. Pithavala, Antonello Abbattista, Gerson Peltz, Enriqueta Felip

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

    Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2 -н Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F. Gainor, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: